Citation Impact
Citing Papers
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
2003 Standout
Endogenous human microRNAs that suppress breast cancer metastasis
2008 StandoutNature
Cell mechanics and the cytoskeleton
2010 StandoutNature
EGFR Antagonists in Cancer Treatment
2008 Standout
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
2011 Standout
Preparation of long-circulating immunoliposomes containing adriamycin by a novel method to coat immunoliposomes with poly(ethylene glycol)
1995
Growth Dominance of the Metastatic Cancer Cell: Cellular and Molecular Aspects
1990
Mesoporous silica nanoparticles in biomedical applications
2012 StandoutNobel
Unique Tumor-Specific Antigens
1988
Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin
2001
Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study
1989
Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice
1988 StandoutNobel
Novel applications of liposomes
1998
Cancer Metastasis: Building a Framework
2006 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies
1996
Micro-Environmental Mechanical Stress Controls Tumor Spheroid Size and Morphology by Suppressing Proliferation and Inducing Apoptosis in Cancer Cells
2009
High intratumoural accumulation of stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and in metastatic brain tumours
2000
Angiogenesis in cancer and other diseases
2000 StandoutNature
A phase II study evaluating the tolerability and efficacy of CAELYX (liposomal doxorubicin, Doxil) in the treatment of unresectable pancreatic carcinoma
2001
Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis
1991
Tumor targeting using anti-her2 immunoliposomes
2001
Pharmacokinetics of Pegylated Liposomal Doxorubicin
2003
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Role of concomitant resistance in the development of murine lung metastases
1988
Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor Penetration
2011 StandoutNobel
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma
2001
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
1991 Standout
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice
1999
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
1994 Standout
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
2004 Standout
Solid stress inhibits the growth of multicellular tumor spheroids
1997
Phase I Study of Paclitaxel (Taxol) and Pegylated Liposomal Doxorubicin (Caelyx) Administered Every 2 Weeks in Patients with Advanced Solid Tumors
2002
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
Transforming Growth Factor β in Tissue Fibrosis
1994 Standout
Pharmacokinetics and antitumor activity of epirubicin encapsulated in long‐circulating liposomes incorporating a polyethylene glycol‐derivatized phospholipid
1992
Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
1988 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Anti-tumor activity of liposome encapsulated fluoroorotic acid as a single agent and in combination with liposome irinotecan
2011
Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients
1990
Caelyx®
2001
Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: An in vivo proof-of-concept study
2010
Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy
1994
Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice
1999 StandoutNobel
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.
1995
Angiogenesis as a therapeutic target
2005 StandoutNature
Tumor Angiogenesis
2008 Standout
Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma
1996
Heterotypic Signaling between Epithelial Tumor Cells and Fibroblasts in Carcinoma Formation
2001
Breast cancer metastasis: markers and models
2005 Standout
Phase I Trial of Pegylated Liposomal Doxorubicin and Docetaxel in Advanced Breast Cancer
2001
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.
1992 StandoutNobel
Cellular Immunity Against Rous Sarcomas of Chickens. Preferential Reactivity Against Autochthonous Target Cells as Determined by Lymphocyte Adherence and Cytotoxicity Tests In Vitro
1974
Targeted and Equally Distributed Delivery of mRNA to Organs with Pentaerythritol-Based One-Component Ionizable Amphiphilic Janus Dendrimers
2023 StandoutNobel
Bottom-Up Design and Synthesis of Limit Size Lipid Nanoparticle Systems with Aqueous and Triglyceride Cores Using Millisecond Microfluidic Mixing
2012
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
1997 Standout
Selection and altered properties of brain-colonising metastatic melanoma
1978 Nature
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Molecular insights into renal interstitial fibrosis.
1996
Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture.
1981
Dexamethasone-mediated induction of mouse mammary tumor virus RNA: a system for studying glucocorticoid action
1975 StandoutNobel
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Concomitant Tumor Immunity and the Resistance to a Second Tumor Challenge
1983
Cancer Metastasis: Experimental Approaches, Theoretical Concepts, and Impacts for Treatment Strategies
1985
The Choice of Animal Tumors for Experimental Studies of Cancer Therapy
1978
Back to the drawing board—the need for more realistic model systems for immunotherapy
1977
Host-virus interactions in murine mammary carcinogenesis
1974
Down-Regulation of the Antitumor Immune Response
1985
Conjugated Polymer-Based Chemical Sensors
2000 Standout
Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
2002 StandoutScience
Macrophage-mediated induction of drug-resistant variants in a mouse mammary tumor cell line.
1986
Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft.
1994
Colony Inhibition of Fibroblasts from Chimeric Dogs Mediated by the Dogs' Own Lymphocytes and Specifically Abrogated by Their Serum
1970 StandoutNobel
Daunoxome® Treatment of Solid Tumors: Preclinical and Clinical Investigations
1994
The Role of Tumor-Associated Macrophages in the Delivery of Liposomal Doxorubicin to Solid Murine Fibrosarcoma Tumors
1997
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor
1975 StandoutNobel
Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer Tumors
2005
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.
1991
Cell and Environment Interactions in Tumor Microregions: The Multicell Spheroid Model
1988 StandoutScience
T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.
1980
“Concomitant immunity” in murine tumours of non-detectable immunogenicity
1985
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
The pathogenesis of cancer metastasis
1980 StandoutNature
Tubulointerstitial Changes as a Major Determinant in the Progression of Renal Damage
1992 Standout
Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells
1993 StandoutScienceNobel
Cancer Genome Landscapes
2013 StandoutScience
Mammary Tumor Viruses
1979
Immunological Surveillance in Neoplasia
1971
Cellular Immunity Against Tumor Antigens
1969
Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors.
1994
Termites: A Potentially Large Source of Atmospheric Methane, Carbon Dioxide, and Molecular Hydrogen
1982 StandoutScienceNobel
Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.
2000
Multiple arrangements of viral DNA and an activated host oncogene in bursal lymphomas
1982 StandoutNatureNobel
Cell-Mediated Immunity to Tumor Cells
1974
The Biology of Cancer Invasion and Metastasis
1978
Phase II study of pegylated liposomal doxorubicin (Caelyx™) as induction chemotherapy for patients with squamous cell cancer of the head and neck
2001
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
1985 Standout
Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: a pediatric oncology group study.
2002
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
1999
The In Vitro Generation of Effector Lymphocytes and Their Employment in Tumor Immunotherapy
1983
A BIOLOGICAL ROLE FOR THE MAJOR HISTOCOMPATIBILITY ANTIGENS
1975 StandoutNobel
Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells
2005 StandoutNobel
Works of Jan Vaage being referenced
A survey of the growth characteristics of and the host reactions to one hundred C3H/He mammary carcinomas.
1978
Radiation-induced changes in established tumor immunity.
1974
Therapy of mouse mammary carcinomas with vincristine and doxorubicin encapsulated in sterically stabilized liposomes
1993
Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal doxorubicin on human prostate carcinoma xenografts
1994
Chemoprevention and therapy of mouse mammary carcinomas with doxorubicin encapsulated in sterically stabilized liposomes
1994
Prophylaxis and therapy of mouse mammary carcinomas with doxorubicin and vincristine encapsulated in sterically stabilised liposomes
1995
Therapy of human ovarian carcinoma xenografts using doxorubicin encapsulated in sterically stabilized liposomes
1993
Tumour uptake of doxorubicin in polyethylene glycol-coated liposomes and therapeutic effect against a xenografted human pancreatic carcinoma
1997
Fibrosis in immune control of mammary‐tumor growth
1992
Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes
1992
A time factor in the success or failure of immune rejection of transplanted tumors.
1977
Metastasizing potentials of mouse mammary tumors and their metastases
1988
Local cellular responses associated with dormancy and regression of a syngeneic C3H mammary carcinoma
1978
Nonvirus-associated antigens in virus-induced mouse mammary tumors.
1968
In vivo and in vitro lysis of mouse cancer cells by antimetastatic effectors in normal plasma
1978
Effect of immune status on the development of artificially induced metastases in different anatomical locations.
1971
Stimulation or inhibition of immune resistance against metastatic or local growth of a C3H mammary carcinoma.
1976
Circulating tumor antigens versus immune serum factors in depressed concomitant immunity.
1974
Immunization against spontaneous and autografted mouse mammary carcinomas in the autochthonous C3H-Crgl mouse.
1969
Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue.
1971
Antigenic differences among virus-induced mouse mammary tumors arising spontaneously in the same C3H-Crgl host.
1969
Pegylated liposomal doxorubicin (DOXIL®, CAELYX®) distribution in tumour models observed with confocal laser scanning microscopy
1998
Effects of Liposome-Entrapped Doxorubicin on Liver Metastases of Mouse Colon Carcinomas 26 and 38<xref ref-type="fn" rid="FN2">2</xref>
1987
Inherent changes in the in vivo growth characteristics of C3H/He mammary carcinomas.
1980
Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
1972
Pharmacokinetics, Biodistribution and Therapeutic Efficacy of Doxorubicin Encapsulated in Stealth® Liposomes (Doxil®)
1994
Virus oncogenesis and tumor immunogenicity in the mouse mammary tumor system.
1974
Production of Collagen Type I by Mouse Peritoneal Macrophages
1990
Tumor-specific resistance in mice detected by inhibition of macrophage migration.
1972
Non-cross-reacting Resistance to Virus Induced Mouse Mammary Tumours in Virus Infected C3H Mice
1968 Nature
Influence of tumor antigen on maintenance versus depression of tumor-specific immunity.
1973